A detailed history of Nebula Research & Development LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 5,849 shares of MEDP stock, worth $3.11 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
5,849
Previous 1,875 211.95%
Holding current value
$3.11 Million
Previous $571 Million 221.33%
% of portfolio
0.16%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$277.23 - $315.28 $1.1 Million - $1.25 Million
3,974 Added 211.95%
5,849 $1.84 Billion
Q1 2025

May 15, 2025

SELL
$304.69 - $360.97 $139,243 - $164,963
-457 Reduced 19.6%
1,875 $571 Million
Q4 2024

Feb 14, 2025

SELL
$308.93 - $363.58 $662,963 - $780,242
-2,146 Reduced 47.92%
2,332 $775 Million
Q3 2024

Nov 14, 2024

BUY
$320.58 - $457.29 $1.44 Million - $2.05 Million
4,478 New
4,478 $1.49 Billion

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $16.5B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.